Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BIO-key International | BKYI | Aug 30, 2024 | 1.33 | +4.72 |
Bio-Path | BPTH | Aug 30, 2024 | 0.99 | +1.87 |
Bio-Rad Laboratories A | BIO | Aug 30, 2024 | 337.32 | +1.08 |
Bio-Rad Laboratories B | BIO-B | Aug 30, 2024 | 326.78 | 0.00 |
Bio-Techne | TECH | Aug 30, 2024 | 73.99 | -0.71 |
BioAffinity Technologies | BIAF | Aug 30, 2024 | 1.50 | -3.23 |
BioAtla | BCAB | Aug 30, 2024 | 1.77 | -2.75 |
BioCardia | BCDA | Aug 30, 2024 | 3.05 | -24.13 |
Bioceres Crop Solutions | BIOX | Aug 30, 2024 | 10.64 | -3.88 |
BioCryst Pharmaceuticals | BCRX | Aug 30, 2024 | 8.69 | +0.70 |
Biodesix | BDSX | Aug 30, 2024 | 1.96 | +5.95 |
Biodexa Pharma ADR | BDRX | Aug 30, 2024 | 0.55 | -0.54 |
Biofrontera | BFRI | Aug 30, 2024 | 1.09 | -1.36 |
Biogen | BIIB | Aug 30, 2024 | 204.76 | -0.03 |
Biohaven | BHVN | Aug 30, 2024 | 39.40 | -1.03 |
Biolase | BIOL | Aug 30, 2024 | 0.13 | 0.00 |
BioLife Solutions | BLFS | Aug 30, 2024 | 25.88 | -0.15 |
BioLineRX ADR | BLRX | Aug 30, 2024 | 0.65 | +0.95 |
BioMarin Pharmaceutical | BMRN | Aug 30, 2024 | 91.21 | -0.18 |
Biomea Fusion | BMEA | Aug 30, 2024 | 7.33 | -3.81 |
Biomerica | BMRA | Aug 30, 2024 | 0.44 | -4.45 |
BiomX | PHGE | Aug 30, 2024 | 1.22 | -3.17 |
Bionano Genomics | BNGO | Aug 30, 2024 | 0.49 | +1.41 |
BioNexus Gene Lab | BGLC | Aug 30, 2024 | 0.44 | +0.18 |
Bionomics ADR | BNOX | Aug 30, 2024 | 0.64 | -0.17 |
BioNTech ADR | BNTX | Aug 30, 2024 | 88.22 | +0.71 |
Biora Therapeutics | BIOR | Aug 30, 2024 | 0.70 | +1.62 |
BioRestorative Therapies | BRTX | Aug 30, 2024 | 1.64 | +0.61 |
BioShares Biotechnology Clinical Trials Fund | BBC | Aug 30, 2024 | 28.02 | +0.93 |
BioShares Biotechnology Products Fund | BBP | Aug 30, 2024 | 64.16 | +0.40 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.